NEW YORK, Dec. 9 (GenomeWeb News) - BioVision will evaluate clinical samples provided by Switzerland-based Novartis Pharmaceuticals as part of a service agreement, BioVision said today.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
